WuXi Biologics (Cayman) Inc
OTC:WXIBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WuXi Biologics (Cayman) Inc
OTC:WXIBF
|
CN |
|
A
|
Astra Exploration Inc
OTC:ATEPF
|
CA |
|
Reece Ltd
OTC:REECF
|
AU |
|
E
|
Enerpac Tool Group Corp
F:PW9
|
US |
|
BBMG Corp
F:9BM
|
CN |
|
Bird Construction Inc
F:6LT
|
CA |
|
Air Canada
TSX:AC
|
CA |
|
Verona Pharma PLC
NASDAQ:VRNA
|
UK |
|
SRT Marine Systems PLC
OTC:SRTMF
|
UK |
|
M
|
Mayr Melnhof Karton AG
XMUN:MYM
|
AT |
|
A
|
Aeterna Zentaris Inc
NASDAQ:AEZS
|
US |
|
A
|
Air Canada
F:ADH2
|
CA |
|
E
|
Edison International
DUS:EIX
|
US |
|
N
|
Nissin Foods Holdings Co Ltd
XBER:NF2
|
JP |
|
Brookfield Business Corp
F:C6E
|
US |
|
M
|
Mitsubishi Chemical Holdings Corp
F:M3C
|
JP |
|
G
|
Genesis AI Corp
OTC:AIGFF
|
CA |
|
Banco Comercial Portugues SA
OTC:BPCGF
|
PT |
|
A
|
AXA SA
F:AXA
|
FR |
|
T
|
Tronox Holdings PLC
F:T5X
|
US |
|
Atos SE
PAR:ATO
|
FR |
|
5
|
5E Advanced Materials Inc
F:J9I
|
US |
|
LuxExperience BV
F:0FV
|
DE |
|
B
|
Bureau Veritas SA
DUS:4BV
|
FR |
Wall St Price Targets
WXIBF Price Targets Summary
WuXi Biologics (Cayman) Inc
According to Wall Street analysts, the average 1-year price target for WXIBF is 5.41 USD with a low forecast of 3.58 USD and a high forecast of 9.66 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is WXIBF's stock price target?
Price Target
5.41
USD
According to Wall Street analysts, the average 1-year price target for WXIBF is 5.41 USD with a low forecast of 3.58 USD and a high forecast of 9.66 USD.
What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%
Over the last 10 years, the compound annual growth rate for Operating Income has been 60%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
18%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 60%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
13%
Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 13%.
